Mitochondrial DNA haplogroups influence AIDS progression.

PubWeight™: 1.29‹?› | Rank: Top 10%

🔗 View Article (PMC 2699618)

Published in AIDS on November 30, 2008

Authors

Sher L Hendrickson1, Holli B Hutcheson, Eduardo Ruiz-Pesini, Jason C Poole, James Lautenberger, Efe Sezgin, Lawrence Kingsley, James J Goedert, David Vlahov, Sharyne Donfield, Douglas C Wallace, Stephen J O'Brien

Author Affiliations

1: Laboratory of Genomic Diversity, National Cancer Institute, Frederick, Maryland 21702-1201, USA. hendricksons@mail.nih.gov

Articles citing this

Mitochondrial energetics and therapeutics. Annu Rev Pathol (2010) 3.07

Energetics, epigenetics, mitochondrial genetics. Mitochondrion (2009) 2.08

The pathophysiology of mitochondrial disease as modeled in the mouse. Genes Dev (2009) 1.87

A mitochondrial etiology of Alzheimer and Parkinson disease. Biochim Biophys Acta (2011) 1.52

Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer (2010) 1.25

Mitochondrial DNA haplogroups influence lipoatrophy after highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2009) 1.24

Association between mitochondrial DNA variations and Alzheimer's disease in the ADNI cohort. Neurobiol Aging (2010) 1.05

Investigating the role of mitochondrial haplogroups in genetic predisposition to meningococcal disease. PLoS One (2009) 1.01

Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. PLoS One (2010) 1.00

Mitochondrial DNA haplogroup background affects LHON, but not suspected LHON, in Chinese patients. PLoS One (2011) 0.96

Mitochondrial DNA copy number, but not haplogroup, confers a genetic susceptibility to leprosy in Han Chinese from Southwest China. PLoS One (2012) 0.88

Multiplex analysis of mitochondrial DNA pathogenic and polymorphic sequence variants. Biol Chem (2010) 0.86

Mitochondrial DNA variation and HIV-associated sensory neuropathy in CHARTER. J Neurovirol (2012) 0.85

Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384. J Acquir Immune Defic Syndr (2011) 0.85

Host genomic influences on HIV/AIDS. Genome Biol (2013) 0.84

The other genome: a systematic review of studies of mitochondrial DNA haplogroups and outcomes of HIV infection and antiretroviral therapy. AIDS Rev (2013) 0.84

Mitochondrial haplogroups are associated with risk of neuroretinal disorder in HIV-positive patients. J Acquir Immune Defic Syndr (2010) 0.83

Common mitochondrial polymorphisms as risk factor for endometrial cancer. Int Arch Med (2009) 0.83

Mitochondrial genomics and antiretroviral therapy-associated metabolic complications in HIV-infected Black South Africans: a pilot study. AIDS Res Hum Retroviruses (2013) 0.82

HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution. J Neurovirol (2016) 0.81

Epidermal nerve fiber density, oxidative stress, and mitochondrial haplogroups in HIV-infected Thais initiating therapy. AIDS (2014) 0.80

The rise of mitochondria in medicine. Mitochondrion (2016) 0.80

Pathways to aging: the mitochondrion at the intersection of biological and psychosocial sciences. J Aging Res (2011) 0.80

Role of mtDNA haplogroups in the prevalence of knee osteoarthritis in a southern Chinese population. Int J Mol Sci (2014) 0.79

Pediatric HIV Long-Term Nonprogressors. Case Rep Infect Dis (2014) 0.77

Mitochondrial DNA variant m.15218A > G in Finnish epilepsy patients who have maternal relatives with epilepsy, sensorineural hearing impairment or diabetes mellitus. BMC Med Genet (2013) 0.77

T cell activation markers and African mitochondrial DNA haplogroups among non-Hispanic black participants in AIDS clinical trials group study 384. PLoS One (2012) 0.77

An exploratory analysis of mitochondrial haplotypes and allogeneic hematopoietic cell transplantation outcomes. Biol Blood Marrow Transplant (2014) 0.75

European Mitochondrial DNA Haplogroups are Associated with Cerebrospinal Fluid Biomarkers of Inflammation in HIV Infection. Pathog Immun (2017) 0.75

Identification of Genes Whose Expression Profile Is Associated with Non-Progression towards AIDS Using eQTLs. PLoS One (2015) 0.75

No effect of mitochondrial genotype on reproductive plasticity following exposure to a non-infectious pathogen challenge in female or male Drosophila. Sci Rep (2017) 0.75

Mitochondrial genotype in vulvar carcinoma - cuckoo in the nest. J Biomed Sci (2010) 0.75

Mitochondrial DNA variation and virologic and immunological HIV outcomes in African Americans. AIDS (2014) 0.75

Articles cited by this

Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet (2006) 115.71

Population structure, differential bias and genomic control in a large-scale, case-control association study. Nat Genet (2005) 25.34

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep (1992) 22.29

A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet (2005) 16.79

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature (2006) 15.69

Mitochondrial membrane permeabilization in cell death. Physiol Rev (2007) 12.72

Discerning the ancestry of European Americans in genetic association studies. PLoS Genet (2007) 7.81

The influence of HLA genotype on AIDS. Annu Rev Med (2001) 7.77

The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr (1991) 7.05

Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci U S A (2002) 6.95

Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. Science (1997) 5.91

Effects of purifying and adaptive selection on regional variation in human mtDNA. Science (2004) 5.87

Organelle-specific initiation of cell death pathways. Nat Cell Biol (2001) 5.03

An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res (2006) 4.51

mtDNA and the origin of Caucasians: identification of ancient Caucasian-specific haplogroups, one of which is prone to a recurrent somatic duplication in the D-loop region. Am J Hum Genet (1994) 4.47

A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia. N Engl J Med (1989) 4.04

Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC) Science (1998) 3.86

Human genes that limit AIDS. Nat Genet (2004) 3.80

Redox regulation of cellular signalling. Cell Signal (1999) 3.65

Haplotype and phylogenetic analyses suggest that one European-specific mtDNA background plays a role in the expression of Leber hereditary optic neuropathy by increasing the penetrance of the primary mutations 11778 and 14484. Am J Hum Genet (1997) 3.48

Long-term HIV-1 infection without immunologic progression. AIDS (1994) 3.41

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet (1999) 3.41

Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. Am J Hum Genet (2003) 3.39

Mitochondrial DNA G10398A polymorphism and invasive breast cancer in African-American women. Cancer Res (2005) 3.26

Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS (1998) 3.16

Human mtDNA haplogroups associated with high or reduced spermatozoa motility. Am J Hum Genet (2000) 2.64

The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J Exp Med (2000) 2.62

Hemophilia growth and development study. Design, methods, and entry data. Am J Pediatr Hematol Oncol (1993) 2.28

Mitochondrial DNA polymorphisms associated with longevity in a Finnish population. Hum Genet (2002) 2.00

Evidence for adaptive selection acting on the tRNA and rRNA genes of human mitochondrial DNA. Hum Mutat (2006) 1.98

Mitochondrial DNA and survival after sepsis: a prospective study. Lancet (2005) 1.85

Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals. Clin Infect Dis (2004) 1.80

NFkappaB pathway: a good signaling paradigm and therapeutic target. Int J Biochem Cell Biol (2006) 1.66

Acquired immune deficiency syndrome occurring within 5 years of infection with human immunodeficiency virus type-1: the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr (1992) 1.57

Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes. Eur J Hum Genet (2005) 1.54

HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. EMBO J (2002) 1.50

A brief overview of mechanisms of mitochondrial toxicity from NRTIs. Environ Mol Mutagen (2007) 1.49

The power to detect disease associations with mitochondrial DNA haplogroups. Am J Hum Genet (2006) 1.49

Antiretroviral nucleosides, deoxynucleotide carrier and mitochondrial DNA: evidence supporting the DNA pol gamma hypothesis. AIDS (2006) 1.43

Mitochondrial haplogroups and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS (2005) 1.39

Patterns of ethnic diversity among the genes that influence AIDS. Hum Mol Genet (2004) 1.34

Association of the mitochondrial DNA haplogroup J with longevity is population specific. Eur J Hum Genet (2004) 1.32

Mitochondrial DNA mutations in diseases of energy metabolism. J Bioenerg Biomembr (1994) 1.28

Polygenic and multifactorial disease gene association in man: Lessons from AIDS. Annu Rev Genet (2000) 1.24

Differences of sperm motility in mitochondrial DNA haplogroup U sublineages. Gene (2005) 1.21

Oxidative DNA damage: assessment of the role in carcinogenesis, atherosclerosis, and acquired immunodeficiency syndrome. Free Radic Biol Med (2002) 1.14

Supplementation with antioxidant vitamins prevents oxidative modification of DNA in lymphocytes of HIV-infected patients. Free Radic Biol Med (2002) 1.10

mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish. Exp Gerontol (2003) 1.09

HIV induces lymphocyte apoptosis by a p53-initiated, mitochondrial-mediated mechanism. FASEB J (2000) 1.08

Depletion of mitochondrial DNA in HIV-1-infected patients and its amelioration by antiretroviral therapy. J Med Virol (2003) 1.05

A C-terminal domain of HIV-1 accessory protein Vpr is involved in penetration, mitochondrial dysfunction and apoptosis of human CD4+ lymphocytes. Apoptosis (1997) 1.04

Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy. Antivir Ther (2005) 1.02

The HIV-1 Vpr displays strong anti-apoptotic activity. FEBS Lett (1998) 1.02

Mitochondrial apoptosis induced by the HIV-1 envelope. Ann N Y Acad Sci (2003) 0.94

Human immunodeficiency virus (HIV) infection codes. Official authorized addendum. ICD-9-CM (Revision No. 1). Effective January 1, 1988. MMWR Morb Mortal Wkly Rep (1987) 0.92

Consistent effects of TSG101 genetic variability on multiple outcomes of exposure to human immunodeficiency virus type 1. J Virol (2006) 0.92

Apoptosis and apoptosis-associated perturbations of peripheral blood lymphocytes during HIV infection: comparison between AIDS patients and asymptomatic long-term non-progressors. Clin Exp Immunol (2000) 0.92

Superoxide enhances the spread of HIV-1 infection by cell-to-cell transmission. FEBS Lett (1993) 0.89

Host factors in the pathogenesis of HIV disease. Antibiot Chemother (1971) (1996) 0.87

Mitochondrial abnormalities in HIV-infected lipoatrophic patients treated with antiretroviral agents. J Acquir Immune Defic Syndr (2004) 0.86

Detecting AIDS restriction genes: from candidate genes to genome-wide association discovery. Vaccine (2008) 0.85

Articles by these authors

Effect of early versus deferred antiretroviral therapy for HIV on survival. N Engl J Med (2009) 19.90

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature (2009) 13.99

Methods for high-density admixture mapping of disease genes. Am J Hum Genet (2004) 12.02

A high-density admixture map for disease gene discovery in african americans. Am J Hum Genet (2004) 10.87

Extension of murine life span by overexpression of catalase targeted to mitochondria. Science (2005) 10.11

Psychological sequelae of the September 11 terrorist attacks in New York City. N Engl J Med (2002) 10.07

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet (2008) 9.00

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science (2004) 8.22

The influence of HLA genotype on AIDS. Annu Rev Med (2001) 7.77

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet (2002) 7.58

Trends in cancer risk among people with AIDS in the United States 1980-2002. AIDS (2006) 7.08

Natural selection shaped regional mtDNA variation in humans. Proc Natl Acad Sci U S A (2002) 6.95

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet (2007) 6.83

Placental mammal diversification and the Cretaceous-Tertiary boundary. Proc Natl Acad Sci U S A (2003) 6.29

Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer (2008) 6.13

Protection against persistence of hepatitis C. Lancet (2002) 5.94

Effects of purifying and adaptive selection on regional variation in human mtDNA. Science (2004) 5.87

The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature (2004) 5.85

Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol (2003) 5.81

Canadian illicit opiate users' views on methadone and other opiate prescription treatment: an exploratory qualitative study. Subst Use Misuse (2002) 5.65

A molecular phylogeny of living primates. PLoS Genet (2011) 5.61

The New York Cancer Project: rationale, organization, design, and baseline characteristics. J Urban Health (2004) 5.21

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol (2011) 4.80

Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci U S A (2008) 4.76

Merkel cell carcinoma and HIV infection. Lancet (2002) 4.72

Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst (2011) 4.69

Initial sequence and comparative analysis of the cat genome. Genome Res (2007) 4.67

mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci U S A (2005) 4.66

An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res (2006) 4.51

A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat Genet (2005) 4.45

Opiates, cocaine and alcohol combinations in accidental drug overdose deaths in New York City, 1990-98. Addiction (2003) 4.25

The epidemiology of post-traumatic stress disorder after disasters. Epidemiol Rev (2005) 4.09

Television images and psychological symptoms after the September 11 terrorist attacks. Psychiatry (2002) 4.07

Mapping by admixture linkage disequilibrium: advances, limitations and guidelines. Nat Rev Genet (2005) 4.04

A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science (2008) 3.95

Trends of probable post-traumatic stress disorder in New York City after the September 11 terrorist attacks. Am J Epidemiol (2003) 3.93

Late presentation for human immunodeficiency virus care in the United States and Canada. Clin Infect Dis (2010) 3.72

The characterization of twenty sequenced human genomes. PLoS Genet (2010) 3.72

A back migration from Asia to sub-Saharan Africa is supported by high-resolution analysis of human Y-chromosome haplotypes. Am J Hum Genet (2002) 3.71

Common genetic variation and the control of HIV-1 in humans. PLoS Genet (2009) 3.68

Genetic restoration of the Florida panther. Science (2010) 3.59

HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis (2007) 3.56

Risk behaviors by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Educ Prev (2002) 3.45

The social epidemiology of substance use. Epidemiol Rev (2004) 3.41

A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS (2002) 3.41

Challenges and facilitating factors in sustaining community-based participatory research partnerships: lessons learned from the Detroit, New York City and Seattle Urban Research Centers. J Urban Health (2006) 3.36

MITOMAP: a human mitochondrial genome database--2004 update. Nucleic Acids Res (2005) 3.35

The late Miocene radiation of modern Felidae: a genetic assessment. Science (2006) 3.35

Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons. Am J Public Health (2004) 3.32

Mammalian phylogenomics comes of age. Trends Genet (2004) 3.31

Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am J Epidemiol (2003) 3.29

AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst (2007) 3.28

Influence of HLA-C expression level on HIV control. Science (2013) 3.27

Associations between HIV infection and subclinical coronary atherosclerosis. Ann Intern Med (2014) 3.24

Mitochondrial genomes reveal an explosive radiation of extinct and extant bears near the Miocene-Pliocene boundary. BMC Evol Biol (2008) 3.21

Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Nat Genet (2011) 3.16

Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep (2002) 3.14

Evaluation of an intervention to increase screening colonoscopy in an urban public hospital setting. J Urban Health (2006) 3.10

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. Clin Infect Dis (2005) 3.06

HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03

Urban health: evidence, challenges, and directions. Annu Rev Public Health (2005) 3.02

AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med (2005) 2.97

Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease. J Infect Dis (2004) 2.91

Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS. Blood (2006) 2.90

Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. J Acquir Immune Defic Syndr (2013) 2.78

Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication. Proc Natl Acad Sci U S A (2004) 2.77

Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst (2013) 2.76

Mortality in HIV-seropositive versus -seronegative persons in the era of highly active antiretroviral therapy: implications for when to initiate therapy. J Infect Dis (2004) 2.71

Limited uptake of hepatitis C treatment among injection drug users. J Community Health (2008) 2.61

Mental health service and medication use in New York City after the September 11, 2001, terrorist attack. Psychiatr Serv (2004) 2.58

Public stem cell banks: considerations of justice in stem cell research and therapy. Hastings Cent Rep (2004) 2.53

Cities and population health. Soc Sci Med (2005) 2.53

Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. Clin Infect Dis (2012) 2.50

Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS (2005) 2.42

High incidence and prevalence of HIV-1 infection in high risk population in Calcutta, India. Int J STD AIDS (2003) 2.41

What predicts psychological resilience after disaster? The role of demographics, resources, and life stress. J Consult Clin Psychol (2007) 2.39

Urban built environment and depression: a multilevel analysis. J Epidemiol Community Health (2005) 2.34

Urban neighborhood poverty and the incidence of depression in a population-based cohort study. Ann Epidemiol (2007) 2.33

Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA (2011) 2.31

Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998. Am J Epidemiol (2002) 2.29

Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS (2008) 2.28

Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the Han Chinese population. Hepatology (2011) 2.24

Platelet cytochrome c oxidase activity and quantity in septic patients. Crit Care Med (2011) 2.23

Elevated risk of lung cancer among people with AIDS. AIDS (2007) 2.20

Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health (2006) 2.20

Trends in U.S. pleural mesothelioma incidence rates following simian virus 40 contamination of early poliovirus vaccines. J Natl Cancer Inst (2003) 2.19

Rapid transmission of hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol (2004) 2.19

Molecular genetics and evolution of melanism in the cat family. Curr Biol (2003) 2.16